Natural Killer Cell-Based Adoptive Immunotherapy Eradicates and Drives Differentiation of Chemoresistant Bladder Cancer Stem-Like Cells
AuthID
P-00M-55N
P-00M-55N
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service